M Parola-Maurizio

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 27, 2025

Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Journal: British journal of cancer

Published: June 26, 2025

The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion.

The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion.

Journal: Hepatology (Baltimore, Md.)

Published: April 17, 2025

Organ Fibrosis: Emerging diagnostic and therapeutic strategies.

Organ Fibrosis: Emerging diagnostic and therapeutic strategies.

Journal: Molecular aspects of medicine

Published: February 27, 2024

Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.

Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.

Journal: Frontiers in immunology

Published: November 21, 2023

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis.

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis.

Journal: Molecular metabolism

Published: October 27, 2023

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies.

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies.

Journal: Molecular aspects of medicine

Published: September 26, 2023

SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness.

SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness.

Journal: Biology

Published: March 07, 2023

The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation.

The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation.

Journal: Alimentary pharmacology & therapeutics

Published: February 17, 2023

Inflammatory processes involved in NASH-related hepatocellular carcinoma.

Inflammatory processes involved in NASH-related hepatocellular carcinoma.

Journal: Bioscience reports

Published: October 18, 2022

Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer.

Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer.

Journal: Cancers

Published: July 14, 2022

Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?

Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?

Journal: Annals of translational medicine

Published: July 13, 2022

Showing 1-12 of 67

Last Updated: 09/26/2026